UBS sees 2027 as the inflection year for $CBRS with revenue growing ~4x to $3.3B before reaching ~$23B by 2030 with 46% operating margins.
The interesting part is Cerebras’s on chip memory advantage becomes way more valuable as AI agents make dozens of model calls per task with CS-5 targeting 10K tokens per second per user in 2027.
And with ~$25B in contracted backlog already equivalent to nearly half of projected revenue from 2027 through 2030, shares now trade below 20x 2028 earnings.